ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Researchers Present Findings at 2016 TRIO Combined Sections Meeting

by Thomas R. Collins • April 11, 2016

  • Tweet
  • Email
Print-Friendly Version

Investigators from around the country and Canada presented their findings at the Triological Society Combined Sections Meeting, held in January in Miami Beach, Fla. Here are some research highlights from the event.

You Might Also Like

  • Otolaryngologists Gather for 2016 TRIO Combined Sections Meeting
  • Panel Discusses Case Management of Head and Neck Cancers at 2016 TRIO Combined Sections Meeting
  • Triological Society Presents Otolaryngology Awards at 2014 Combined Sections Meeting
  • New Otolaryngology Research Highlighted at Trio Sections Meeting
Explore This Issue
April 2016

Causal Network Analysis of Head and Neck Keloid Tissue Identifies Potential Master Regulators

Researchers using DNA analysis and a sophisticated analysis of published literature have found four “master regulators” in charge of four molecular networks that appear to be involved in the development of keloid tumors, offering up future areas of focus for the development of therapies for these hard-to-eliminate lesions.

Keloids are benign fibroproliferative tumors more commonly found in people with darker skin, including African-Americans and Asians. They have an incidence rate of 4% to 16%. One of the most troublesome aspects of keloids is that they recur so frequently after treatment, said Laura Garcia-Rodriguez, MD, a fourth-year resident at Henry Ford Health System in Detroit. “Not only are they aesthetically displeasing, [but] they can cause pain, pruritis, and loss of function,” she said. “The problem with keloids is that there can be up to a 50% recurrence rate. It’s something very hard to explain to a patient who has a very large keloid on [his or her] face.”

Researchers extracted DNA from six keloid tissue samples and six normal tissue samples, then performed genome-wide profiling, finding 152 genes that were differentially methylated between the keloid tissue and the normal tissue.

The 10 with the highest statistical significance were analyzed using causal network analysis (CNA) to find networks with directionality that connect upstream regulators with downstream expression products. The CNA is part of the Ingenuity Pathway Analysis software that includes a database of about five million observations from published literature.

The researchers identified four master regulators and 19 intermediate regulators. A master regulator is a gene or drug positioned as the central or master hub that has the ability to command or influence downstream events, Dr. Garcia-Rodriguez said. She likened master regulators to the conductors of an orchestra and intermediate regulators to individual instruments in an orchestra. The master regulators identified (the chemical drugs tributyrin and pyroxamide, which the analysis showed are likely activated in the relevant networks, and the molecules PRKG2 and PENK, which were predicted to be inactivated) all appear to relate back to tumor protein 53 (TP53), a tumor suppressor.

Inactivation of the p53 tumor suppressor is a frequent event in the development of tumors, and alterations or mutations in the gene are reported to occur in almost every type of cancer, at rates varying between 10% (in hematopoietic malignancies) and close to 100% (in high-grade serous carcinoma of the ovary).

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Features Tagged With: abstracts, keloid analysis, readmission risk, Sections Meeting 2016, tonsillectomy pain, Triological SocietyIssue: April 2016

You Might Also Like:

  • Otolaryngologists Gather for 2016 TRIO Combined Sections Meeting
  • Panel Discusses Case Management of Head and Neck Cancers at 2016 TRIO Combined Sections Meeting
  • Triological Society Presents Otolaryngology Awards at 2014 Combined Sections Meeting
  • New Otolaryngology Research Highlighted at Trio Sections Meeting

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Otolaryngologists Have a Major Role to Play in Treating COVID-19 Long-Haulers
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.